"At Park Nicollet Heart and Vascular Center, we provide extensive cardiovascular services and procedures centered on you. You'll have around-the-clock support from a highly specialized team using the latest innovations - all in a peaceful environment designed for comfort and healing."

During the past decade, Park Nicollet Heart Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Park Nicollet Heart Center" are "Congestive Heart Failure" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Park Nicollet Heart Center" in a lesser frequency.

Most popular intervention types in "Park Nicollet Heart Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CGT003 (E2F Duplex Decoy)" (1 trials) and "Tolvaptan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Park Nicollet Heart Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Park Nicollet Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Park Nicollet Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Park Nicollet Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".